US BANCORP \DE\ - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,492,256
-47.7%
96,461
-46.9%
0.00%
-60.0%
Q2 2023$2,855,433
-22.3%
181,759
-18.4%
0.01%
-16.7%
Q1 2023$3,672,930
+15.9%
222,872
+9.7%
0.01%0.0%
Q4 2022$3,168,204
+139.3%
203,090
+99.0%
0.01%
+100.0%
Q3 2022$1,324,000
-6.4%
102,045
+1.3%
0.00%0.0%
Q2 2022$1,414,000
-20.2%
100,743
-18.6%
0.00%0.0%
Q1 2022$1,771,000
+20.9%
123,728
+15.2%
0.00%
+50.0%
Q4 2021$1,465,000
+13.0%
107,430
+35.8%
0.00%0.0%
Q3 2021$1,296,000
+41.8%
79,129
+45.8%
0.00%0.0%
Q2 2021$914,000
-7.6%
54,280
+0.2%
0.00%0.0%
Q1 2021$989,000
+15.1%
54,167
+14.7%
0.00%0.0%
Q4 2020$859,000
+6.3%
47,207
+4.2%
0.00%0.0%
Q3 2020$808,000
+14.9%
45,311
+15.6%
0.00%0.0%
Q2 2020$703,000
+44.4%
39,208
+22.1%
0.00%0.0%
Q1 2020$487,000
-46.2%
32,112
-30.0%
0.00%0.0%
Q4 2019$905,000
+2.6%
45,883
-10.6%
0.00%0.0%
Q3 2019$882,000
+15.1%
51,321
+18.5%
0.00%0.0%
Q2 2019$766,000
-33.8%
43,315
-23.7%
0.00%
-33.3%
Q1 2019$1,157,000
+425.9%
56,798
+335.2%
0.00%
+200.0%
Q4 2018$220,00013,0500.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders